Skip to main content
SpringerLink
Log in

Human lymphokine-activated killer (LAK) cells: III. Effect ofl-phenylalanine methyl ester on LAK cell activation from human peripheral blood mononuclear cells: Possible protease involvement of monocytes, natural killer cells and LAK cells

  • Original articles
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

We have shown that depletion of monocytes from human peripheral blood mononuclear cells (PBMC) byl-phenylalanine methyl ester (PheOMe) enhanced lymphokine-activated killer cell (LAK) generation by recombinant interleukin-2 (rIL-2) at high cell density. In this study, we have investigated the mechanism of action of PheOMe on LAK activation by using trypsin, chymotrypsin, tosylphenylalaninechloromethanol (TPCK, a chymotrypsin inhibitor), tosyl-l-lysinechloromethane (TLCK, a trypsin inhibitor), phenylalaninol (PheOH), and benzamidine. PBMC were treated with 1–5 mM PheOMe for 40 min at room temperature in combination with the various agents, washed and assessed for their effects on natural killer (NK) activity against K562 cells and monocyte depletion. The treated cells were then cultured with or without rIL-2 for 3 days. LAK cytotoxicity was assayed against51Cr-labeled K562 and Raji tumor target cells. TPCK at 10 µg/ml partially inhibited depletion of monocytes by PheOMe. TLCK did not prevent depletion of monocytes nor inhibition of NK activity induced by PheOMe. TPCK and TLCK inhibited NK activity by themselves. TPCK but not TLCK inhibited rIL-2 induction of LAK cells. On the other hand, PheOH and benzamidine (analogs of PheOMe) lacked any effect on monocyte depletion but abrogated the inhibitory effect of PheOMe on NK activity. They had no effect on rIL-2 activation of LAK activity enhanced by PheOMe. Trypsin potentiated the inhibitory effect of PheOMe on NK activity and monocyte depletion. Trypsin partially inhibited IL-2 activation of LAK activity enhanced by PheOMe. Chymotrypsin had little effect on NK activity but prevented the inhibitory effect of PheOMe on NK activity. It had little effect on monocyte depletion induced by PheOMe. PheOMe was hydrolysed by monocytes and chymotrypsin to Phe and methanol as determined by HPLC. TPCK inhibited hydrolysis of PheOMe by monocytes. Our data suggest that the effects of PheOMe on monocytes, NK cells and LAK activation involve protease activities of monocytes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barlozzari T, Reynolds CW, Herberman RB (1983) In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats. J Immunol 131: 1024

    PubMed  Google Scholar 

  2. Goldman R, Kaplan A (1973) Rupture of rat liver lysosomes mediated byl-amino acid esters. Biochim Biophys Acta 318: 205–216

    PubMed  Google Scholar 

  3. Goldman R, Naider F (1974) Permeation and stereospecificity of hydrolysis of peptide esters within intact lysosomes in vitro. Biochim Biophys Acta 333: 224–233

    Google Scholar 

  4. Grimm EA, Mazumder A, Zhang HZ, Rosenberg SA (1982) Lymphokine-activated killer cell phenomenon: lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J Exp Med 155: 1823–1841

    PubMed  Google Scholar 

  5. Hameed A, Lowrey DM, Lichtenheld M, Podack ER (1988) Characterization of three serine esterases isolated from human IL-2 activated killer cells. J Immunol 141: 3142–3147

    PubMed  Google Scholar 

  6. Hoyer M, Meineko T, Lewis W, Zwilling B, Rinehart J (1986) Characterization and modulation of human lymphokine activated killer cell induction. Cancer Res 46: 2834

    PubMed  Google Scholar 

  7. Kamada MM, Michon J, Ritz J et al (1989). Identification of carboxypeptidase and tryptic esterase activities that are complexed to proteoglycans in the secretory granules of human cloned natural killer cells. J Immunol 142: 609–615

    PubMed  Google Scholar 

  8. Lavie G, Zucker-Franklin D (1989) Cell surface-associated proteinases in NK cell-mediated cytotoxicity: enhancement of enzyme expression is unique to activation with interferon γ. Cell Immunol 124: 202–211

    PubMed  Google Scholar 

  9. Leung KH, Koren HS (1982) Regulation of human natural killing: II. Protective effect of interferon on NK cells from suppression by PGE2. J Immunol 129: 1742

    PubMed  Google Scholar 

  10. Leung KH (1989) Human lymphokine-activated killer (LAK) cells: I. Depletion of monocytes from peripheral blood mononuclear cells byl-phenylalanine methyl ester: an optimaization of LAK cell generation at high cell density. Cancer Immunol Immunother 30: 247

    PubMed  Google Scholar 

  11. Mule JJ, Ettinghausen SE, Spiess PJ, Shu S, Rosenberg SA (1986) Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy. Cancer Res 46: 676

    PubMed  Google Scholar 

  12. Owen-Schaub LB, London WG, Yagita M, Grimm EA (1988) Functional differentiation of human lymphokine-activated killing (LAK) is distinct from expansion and involves dissimilar interleukin 2 receptors. Cell Immunol 111: 235–246

    PubMed  Google Scholar 

  13. Phillips JH, Lanier LL (1986) Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J Exp Med 164: 814

    PubMed  Google Scholar 

  14. Reeves JP (1979) Accumulation of amino acids by lysosomes incubated with amino acid methyl esters. J Biol Chem 254: 8914–8921

    PubMed  Google Scholar 

  15. Reeves JP, Decker RS, Grie JS, Wildenthal K (1981) Intracellular disruption of rat heart lysosomes by leucine methyl ester: effects on protein degradation. Proc Natl Acad Sci USA 78: 4426–4429

    PubMed  Google Scholar 

  16. Rosenberg SA, Lotze MT, Mul JJ (1988) New approaches to the immunotherapy of cancer using interleukin-2. Ann Intern Med 108: 853

    PubMed  Google Scholar 

  17. Thiele DL, Lipsky PE (1985) Regulation of cellular function by products of lysosomal enyzme activity: elimination of human natural killer cells by a dipeptide ethyl ester generated froml-leucine methyl ester by monocytes or polymorphonuclear leukocytes. Proc Natl Acad Sci USA 82: 2468–2472

    PubMed  Google Scholar 

  18. Thiele DL, Lipsky PE (1985) Modulation of human natural killer cell function byl-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells. J Immunol 134: 786–793

    PubMed  Google Scholar 

  19. Thiele DL, Lipsky PE (1986) Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets. J Immunol 137: 1399–1406

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Products Department, Glenolden Laboratory, E. I. du Pont de Nemours and Co., 500 S. Ridgeway Avenue, 19 036, Glenolden, PA, USA

    Kam H. Leung

Authors
  1. Kam H. Leung
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Leung, K.H. Human lymphokine-activated killer (LAK) cells: III. Effect ofl-phenylalanine methyl ester on LAK cell activation from human peripheral blood mononuclear cells: Possible protease involvement of monocytes, natural killer cells and LAK cells. Cancer Immunol Immunother 34, 31–36 (1991). https://doi.org/10.1007/BF01741321

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01741321

Key words

Search

Navigation